Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique

SC Lin, E Heba, T Wolfson, B Ang, A Gamst… - Clinical …, 2015 - Elsevier
Background & Aims Liver biopsy analysis is the standard method used to diagnose
nonalcoholic fatty liver disease (NAFLD). Advanced magnetic resonance imaging is a …

Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD

N Tamaki, V Ajmera, R Loomba - Nature Reviews Endocrinology, 2022 - nature.com
Hepatic steatosis is a key histological feature of nonalcoholic fatty liver disease (NAFLD).
The non-invasive quantification of liver fat is now possible due to advances in imaging …

Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort

C Beyer, C Hutton, A Andersson, K Imajo, A Nakajima… - PLoS …, 2021 - journals.plos.org
Background & aims MRI-based proton density fat fraction (PDFF) and the ultrasound-derived
controlled attenuation parameter (CAP) are non-invasive techniques for quantifying liver fat …

Ultrasound Attenuation Imaging vs MRI-PDFF, Echogenicity and Liver Function for Assessing Degree of Steatosis in NAFLD and Non-NAFLD Patients

M Thomas, M Dighe, O Kolokythas, M Zecevic… - Ultrasound …, 2023 - journals.lww.com
Ultrasound Attenuation Imaging vs MRI-PDFF, Echogenicity and... : Ultrasound Quarterly
Ultrasound Attenuation Imaging vs MRI-PDFF, Echogenicity and Liver Function for Assessing …

Multi-parametric MRI can diagnose steatohepatitis and cirrhosis in patients with NAFLD: 1085

M Pavlides, R Banerjee, EM Tunnicliffe, J Collier… - Hepatology, 2014 - journals.lww.com
Magnetic Resonance Imaging (MRI) is increasingly used to assess liver disease. In this
study we investigated whether a multi-parametric MRI protocol could be used to evaluate …

What's new in hepatic steatosis

M Virarkar, J Szklaruk, CT Jensen, MW Taggart… - Seminars in Ultrasound …, 2021 - Elsevier
Hepatic steatosis can lead to liver cancer, cirrhosis, and portal hypertension. There are two
main types, non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease. The …

Diagnostic performance of 9 quantitative ultrasound parameters for detection and classification of hepatic steatosis in nonalcoholic fatty liver disease

AM Pirmoazen, A Khurana, AM Loening… - Investigative …, 2022 - journals.lww.com
Background Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver
disease worldwide. Quantitative ultrasound (QUS) parameters based on radiofrequency raw …

[HTML][HTML] Imaging biomarkers of NAFLD, NASH, and fibrosis

V Ajmera, R Loomba - Molecular metabolism, 2021 - Elsevier
Background Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic entity that
requires a liver biopsy assessment to diagnose the progressive form of NAFLD called non …

Noninvasive assessment of hepatic steatosis

SM Mazhar, M Shiehmorteza, CB Sirlin - Clinical Gastroenterology and …, 2009 - Elsevier
Hepatic steatosis, the accumulation of lipids within hepatocytes, is a common condition. The
prevalence of its most frequent manifestation, nonalcoholic fatty liver disease (NAFLD), has …

Usefulness of different imaging modalities in evaluation of patients with non-alcoholic fatty liver disease

K Grąt, M Grąt, O Rowiński - Biomedicines, 2020 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
becoming some of the major health problems in well-developed countries, together with the …